LWM
TAK icon

Lenox Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Lenox Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2K Hold
114
– – ﹤0.01% 652
2020
Q1 		$1K Sell
114
-155
-58% -$2.81K ﹤0.01% 676
2019
Q4 		$5K Buy
269
+114
+74% +$2.18K ﹤0.01% 544
2019
Q3 		$2K Buy
155
+82
+112% +$1.42K ﹤0.01% 636
2019
Q2 		$1K Sell
73
-4
-5% -$73 ﹤0.01% 655
2019
Q1 		$2K Buy
+77
New +$1.55K ﹤0.01% 618

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Lenox Wealth Management's TAK Position: Q2 2020 in Review

Lenox Wealth Management held its Takeda Pharmaceutical (TAK) position steady in Q2 2020 at 114 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Lenox Wealth Management first reported a position in TAK in Q1 2019 and has held it in 6 quarters since. The position peaked at $5K in Q4 2019. 308 funds tracked by Wall St. Rank hold TAK as of Q2 2020.

  • Lenox Wealth Management held 114 shares of Takeda Pharmaceutical worth $2K as of Q2 2020.
  • Lenox Wealth Management left its Takeda Pharmaceutical share count unchanged in Q2 2020.
  • Takeda Pharmaceutical made up ﹤0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #652 holding.
  • Lenox Wealth Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 6 quarters since.
  • Lenox Wealth Management's Takeda Pharmaceutical position peaked at $5K in Q4 2019.
  • 308 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.